WO2002002610A3 - Secretion and trafficking molecules - Google Patents

Secretion and trafficking molecules Download PDF

Info

Publication number
WO2002002610A3
WO2002002610A3 PCT/US2001/020704 US0120704W WO0202610A3 WO 2002002610 A3 WO2002002610 A3 WO 2002002610A3 US 0120704 W US0120704 W US 0120704W WO 0202610 A3 WO0202610 A3 WO 0202610A3
Authority
WO
WIPO (PCT)
Prior art keywords
sat
secretion
trafficking molecules
provides
trafficking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/020704
Other languages
French (fr)
Other versions
WO2002002610A2 (en
Inventor
Ernestine A Lee
Yan Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to EP01952303A priority Critical patent/EP1294884A2/en
Priority to AU2001273070A priority patent/AU2001273070A1/en
Priority to CA002410679A priority patent/CA2410679A1/en
Priority to JP2002507862A priority patent/JP2004528002A/en
Publication of WO2002002610A2 publication Critical patent/WO2002002610A2/en
Publication of WO2002002610A3 publication Critical patent/WO2002002610A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides human secretion and trafficking molecules (SAT) and polynucleotides which identify and encode SAT. The invetion also provides expression vectors, host cells, antibodies, agonists and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SAT.
PCT/US2001/020704 2000-06-29 2001-06-28 Secretion and trafficking molecules Ceased WO2002002610A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01952303A EP1294884A2 (en) 2000-06-29 2001-06-28 Secretion and trafficking molecules
AU2001273070A AU2001273070A1 (en) 2000-06-29 2001-06-28 Secretion and trafficking molecules
CA002410679A CA2410679A1 (en) 2000-06-29 2001-06-28 Secretion and trafficking molecules
JP2002507862A JP2004528002A (en) 2000-06-29 2001-06-28 Secretory and transport molecules

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21546500P 2000-06-29 2000-06-29
US60/215,465 2000-06-29
US23938400P 2000-10-10 2000-10-10
US60/239,384 2000-10-10
US25363900P 2000-11-28 2000-11-28
US60/253,639 2000-11-28

Publications (2)

Publication Number Publication Date
WO2002002610A2 WO2002002610A2 (en) 2002-01-10
WO2002002610A3 true WO2002002610A3 (en) 2002-09-19

Family

ID=27396128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020704 Ceased WO2002002610A2 (en) 2000-06-29 2001-06-28 Secretion and trafficking molecules

Country Status (5)

Country Link
EP (1) EP1294884A2 (en)
JP (1) JP2004528002A (en)
AU (1) AU2001273070A1 (en)
CA (1) CA2410679A1 (en)
WO (1) WO2002002610A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053591A1 (en) * 2000-12-30 2002-07-11 Lion Bioscience Ag Mammalian nuclear receptor cofactor cf12 and methods of use
WO2002053585A2 (en) * 2000-12-30 2002-07-11 Lion Bioscience Ag Mammalian nuclear receptor cofactor cf11 and methods of use
WO2003093466A1 (en) * 2002-05-02 2003-11-13 Bayer Healthcare Ag Human rhomboid-related protein
WO2005090569A1 (en) * 2004-03-24 2005-09-29 The Council Of The Queensland Institute Of Medical Research Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
CA2730923A1 (en) * 2008-07-18 2010-01-21 University Of Medicine And Dentistry Of New Jersey Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025699A1 (en) * 1992-06-11 1993-12-23 The Regents Of The University Of California Vesicle membrane transport proteins
WO1998037094A2 (en) * 1997-02-24 1998-08-27 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999016875A1 (en) * 1997-09-30 1999-04-08 Yale University A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells
WO2000012703A2 (en) * 1998-08-27 2000-03-09 Incyte Pharmaceuticals, Inc. Protein transport-associated molecules
EP1033401A2 (en) * 1999-02-26 2000-09-06 Genset Expressed sequence tags and encoded human proteins
WO2000056767A1 (en) * 1999-03-19 2000-09-28 Human Genome Sciences, Inc. 46 human secreted proteins

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025699A1 (en) * 1992-06-11 1993-12-23 The Regents Of The University Of California Vesicle membrane transport proteins
WO1998037094A2 (en) * 1997-02-24 1998-08-27 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999016875A1 (en) * 1997-09-30 1999-04-08 Yale University A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells
WO2000012703A2 (en) * 1998-08-27 2000-03-09 Incyte Pharmaceuticals, Inc. Protein transport-associated molecules
EP1033401A2 (en) * 1999-02-26 2000-09-06 Genset Expressed sequence tags and encoded human proteins
WO2000056767A1 (en) * 1999-03-19 2000-09-28 Human Genome Sciences, Inc. 46 human secreted proteins

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL SEQUENCE DATABASE Hinxton, UK; 18 June 2000 (2000-06-18), R.H. WATERSTON: "Homo sapiens chromosome 2 xlone RP11-803F15", XP002193349 *
DATABASE EMBL SEQUENCE DATABASE Hinxton, UK; 23 September 1999 (1999-09-23), J.E. SULSTON AND R. WATERSON: "Homo sapiens BAC clone RP11-395N3 from 2, complete sequence", XP002193417 *
DATABASE GENSEQ DATABASE NCBI, US; 6 October 2000 (2000-10-06), GENSET: "Human secreted proteins 5' EST , SEQ ID No: 23886", XP002193416 *
DATABASE GENSEQ SEQUENCE DATABASE Hinxton, UK; 2 February 2001 (2001-02-02), HUMAN GENOME SCI INC: "Human secreted protein sequence #39", XP002193348 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Also Published As

Publication number Publication date
EP1294884A2 (en) 2003-03-26
AU2001273070A1 (en) 2002-01-14
CA2410679A1 (en) 2002-01-10
WO2002002610A2 (en) 2002-01-10
JP2004528002A (en) 2004-09-16

Similar Documents

Publication Publication Date Title
WO2000070049A3 (en) Extracellular signaling molecules
WO2001012662A3 (en) Membrane associated proteins
WO2002046383A3 (en) Protein modification and maintenance molecules
WO2002063005A3 (en) Lipid-associated molecules
WO2002038602A3 (en) Secreted proteins
WO2001098353A3 (en) Secreted proteins
WO2001098354A3 (en) Human receptors
WO2002048337A3 (en) Secreted human proteins
WO2001072777A3 (en) Human transcription factors
WO2001079291A3 (en) Secreted proteins
WO2002026950A3 (en) Transferases
WO2002034783A3 (en) Transmembrane proteins
WO2001032888A3 (en) Human transferase molecules
WO2001096546A3 (en) Protein phosphatases
WO2001085942A3 (en) Cytoskeleton-associated proteins
WO2002010363A3 (en) Protein phosphatases
WO1999041373A3 (en) Human transport-associated molecules
WO2002002610A3 (en) Secretion and trafficking molecules
WO2000065054A3 (en) Human membrane-associated proteins
WO2002026982A3 (en) Secreted human proteins
WO2002024924A3 (en) Protein phosphatases
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2001092527A3 (en) Regulators of apoptosis
WO2002026998A3 (en) Hydrolases
WO2001051636A3 (en) Secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2410679

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 507862

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001952303

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001952303

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10311626

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001952303

Country of ref document: EP